GLP-1-based agonists (GLP-1s) are showing positive results in preventing or reversing chronic conditions such as sleep apnea, fatty liver, and CVD. Recent research indicates GLP-1s can improve cardiovascular health, liver function, sleep apnea, kidney health, and reduce inflammation in the body. While medications like GLP-1s are promising, lifestyle changes and behavior modifications are also crucial for long-term success in managing chronic conditions. Despite challenges like supply chain issues and costs, ongoing research on GLP-1s may make them more accessible in the future. Dr. Tim Church is a leading expert in exercise and obesity research, advocating for preventive health strategies to empower organizations and individuals to improve their health.
Source link